Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230541 · ClinicalTrials.gov registry record · Phase 1
Effect of Udenafil on Spermatogenesis
A Phase 1 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 1
- Development phase
- 239
- Enrollment target
NCT01230541: Completed Phase 1 study, sponsored by Warner Chilcott.
NCT01230541 is a Phase 1 study that has completed, run by Warner Chilcott. The registered enrollment target is 239 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (298% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01230541, a Phase 1 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 239 participants
- Enrollment target
Study Summary
Study of udenafil daily in subjects with mild or no erectile dysfunction to evaluate effects on semen characteristics.
Primary Outcome
Percentage of Subjects with greater than or equal to 50% decrease from baseline in sperm concentration at 26 weeks
Interventions
- DRUG Placebo
- DRUG Udenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
What the finished NCT01230541 record still lists
NCT01230541 is an interventional study that assigns participants to a tested intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (298% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01230541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01230541 about?
NCT01230541 is a clinical study titled "Effect of Udenafil on Spermatogenesis". Study of udenafil daily in subjects with mild or no erectile dysfunction to evaluate effects on semen characteristics.
What is the current status of trial NCT01230541?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 239 participants. The study started on 2010-09. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01230541?
The interventions under investigation include: Placebo (DRUG), Udenafil (DRUG).
Who is sponsoring clinical trial NCT01230541?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01230541's enrollment target sits among peer trials
239 212th of 2000 higher than 1,789 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia